DrugPatentWatch Database Preview
LOVENOX (PRESERVATIVE FREE) Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Lovenox (preservative Free) patents expire, and what generic alternatives are available?
Lovenox (preservative Free) is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in LOVENOX (PRESERVATIVE FREE) is enoxaparin sodium. There are thirteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
Summary for LOVENOX (PRESERVATIVE FREE)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 4 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LOVENOX (PRESERVATIVE FREE) at DailyMed |
-patent-expirations.png "LOVENOX (PRESERVATIVE FREE) drug patent expirations")
Pharmacology for LOVENOX (PRESERVATIVE FREE)
| Drug Class | Low Molecular Weight Heparin |
Paragraph IV (Patent) Challenges for LOVENOX (PRESERVATIVE FREE)
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| LOVENOX (PRESERVATIVE FREE) | INJECTABLE;SUBCUTANEOUS | enoxaparin sodium | 020164 | 2006-12-07 |
| LOVENOX | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | enoxaparin sodium | 020164 | 2006-12-07 |
US Patents and Regulatory Information for LOVENOX (PRESERVATIVE FREE)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-001 | Mar 29, 1993 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-007 | Jun 2, 2000 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-004 | Mar 27, 1998 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-008 | Jun 2, 2000 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-002 | Jan 30, 1998 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-003 | Mar 27, 1998 | AP | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LOVENOX (PRESERVATIVE FREE)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-006 | Jun 2, 2000 | Start Trial | Start Trial |
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-006 | Jun 2, 2000 | Start Trial | Start Trial |
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-002 | Jan 30, 1998 | Start Trial | Start Trial |
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-005 | Mar 27, 1998 | Start Trial | Start Trial |
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-004 | Mar 27, 1998 | Start Trial | Start Trial |
| Sanofi Aventis Us | LOVENOX (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 020164-003 | Mar 27, 1998 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
